JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hayashida, K.
Right arrow Articles by Kimura, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hayashida, K.
Right arrow Articles by Kimura, K.
Journal of Nuclear Medicine Vol. 42 No. 6 859-863
© 2001 by Society of Nuclear Medicine


CLINICAL INVESTIGATIONS

Embolic Distribution Through Patent Foramen Ovale Demonstrated by 99mTc-MAA Brain SPECT After Valsalva Radionuclide Venography

Kohei Hayashida, Kazuki Fukuchi, Masayuki Inubushi, Kazuhito Fukushima, Satoshi Imakita and Kazumi Kimura

Departments of Radiology and Medicine, National Cardiovascular Center, Osaka, Japan

Cryptogenic stroke might relate to paradoxical embolism stemming from right-to-left shunt caused by patent foramen ovale (PFO). We performed radionuclide venography using the Valsalva maneuver, followed by 99mTc-macroaggregated albumin (MAA) brain SPECT to investigate the fate of emboli originating from the lower extremities. Methods: Ten patients (9 men, 1 woman; mean age, 61 ± 17 y) with PFO underwent radionuclide venography with and without the Valsalva maneuver on the whole-body image, followed by brain SPECT with 99mTc-MAA to determine the cortical uptake that would detect right-to-left shunt. After counts in each region of interest (ROI) were normalized by comparison with the averaged count, the distribution of MAA was compared with that of 99mTc–hexamethyl-propyleneamine oxime (HMPAO) brain SPECT by drawing ROIs on frontal, temporoparietal (anterior circulation territory), occipital, and cerebellar areas (posterior circulation territory). Results: The thyroid on the whole-body scan was visualized after the Valsalva maneuver in 2 of the 10 patients. In 7 of 10 patients, 56 ROIs in the visualized cortical uptake showed that the distribution of MAA correlated well with that of HMPAO according to the equation: HMPAO = -71.21 + 1.71 x MAA, (r = 0.575, P < 0.01). The excess difference in the relative counts in the posterior over anterior circulation territory was 5.6% and 16.1% of the HMPAO and MAA values, respectively. Conclusion: Brain SPECT with 99mTc-MAA was more sensitive than thyroid visualization in detecting right-to-left shunt. The excess flow in the posterior cerebral circulation indicated an increased likelihood of cerebral emboli originating from the lower extremities and indicated that the flow difference between HMPAO and MAA probably resulted from poor linearization of HMPAO in the high-flow area.

Key Words: cerebral embolism • patent foramen ovale • radionuclide venography • 99mTc-microaggregated albumin • brain SPECT




This article has been cited by other articles:


Home page
NeurologyHome page
A. Adami, G. Rossato, R. Cerini, V. N. Thijs, R. Pozzi-Mucelli, G. P. Anzola, M. D. Sette, C. Finocchi, G. Meneghetti, C. Zanferrari, et al.
Right-to-left shunt does not increase white matter lesion load in migraine with aura patients
Neurology, July 8, 2008; 71(2): 101 - 107.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. Jauss, T. Wessels, S. Trittmacher, J. Allendorfer, and M. Kaps
Embolic Lesion Pattern in Stroke Patients With Patent Foramen Ovale Compared With Patients Lacking an Embolic Source
Stroke, August 1, 2006; 37(8): 2159 - 2161.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. Nilsson, R. H. Larsen, S. D. Fossa, L. Balteskard, K. W. Borch, J.-E. Westlin, G. Salberg, and O. S. Bruland
First Clinical Experience with {alpha}-Emitting Radium-223 in the Treatment of Skeletal Metastases
Clin. Cancer Res., June 15, 2005; 11(12): 4451 - 4459.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
M. B. Horowitz, R. Carrau, D. Crammond, and E. Kanal
Risks of Tumor Embolization in the Presence of an Unrecognized Patent Foramen Ovale: Case Report
AJNR Am. J. Neuroradiol., June 1, 2002; 23(6): 982 - 984.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2001 by the Society of Nuclear Medicine.